ADI Launches the Alzheimer’s Disease Atlas
Access the world's first of its kind platform highlighting how countries diagnose, treat and support people living with dementia.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
Highlights from the National Dementia Plan Pan Regional Workshop 2026
Government representatives, dementia associations and WHO experts gathered in London to share progress, tackle challenges and strengthen collaboration on developing and implementing effective National Dementia Plans worldwide.
ADI attends the 79th World Health Assembly
Highlights from the 79th World Health Assembly, a round-up of ADI's engagements at the annual gathering at WHO Headquarters, Geneva, Switzerland.
New Alzheimer’s blood tests to detect Alzheimer’s pathology gain European Conformity mark
In May 2026, two blood tests have received a Conformité Européenne (CE) mark for within the European Economic Area (EEA), including Elecsys® pTau217, developed by Roche in collaboration with Eli Lilly, as well as the Lumipulse G pTau 217 Plasma assay by Fujirebio Europe N.V.
People living with dementia and their families need clear guidance when weighing choices of new Alzheimer’s treatments
A commentary in response to the recent Cochrane review of clinical trial data on different anti-amyloid treatments, that states these medicines show ‘no clinically meaningful benefit’ for people with Alzheimer’s.
Americas takes Action in April; From regional declarations to national advocacy
In April, there has been a plethora of activity around dementia and brain health policy, as governments, regional bodies, and civil society strengthen collaboration to address one of the region’s fastest-growing public health challenges.
Highlights from the 37th Global Conference of ADI
The 37th Global Conference of Alzheimer’s Disease International (ADI 2026) brought together a truly global collective in Lyon, uniting over 1,500 delegates from more than 90 countries. With 1,133 abstracts submitted and 672 posters presented, the conference showcased the breadth of innovation, research and collaboration shaping the future of dementia…
Launching the Alzheimer’s Disease Atlas at ADI2026 Conference
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
ADI CEO delivers speech at French Ministry of Health ahead of ADI2026 Conference
Read the transcript of ADI CEO Paola Barbarino's full speech at the French Ministry of Health, in Paris, France, 10 April 2026.
Cognitive rehabilitation and living well after an Alzheimer’s diagnosis – A case study by Moneta Health
As part of ADI’s ongoing work to share global voices of those living with dementia, we are pleased to share a case study provided by Moneta Health, highlighting the importance of cognitive rehabilitation within post-diagnostic support. The case study features the words of Dahlia, who was diagnosed with early onset Alzheimer's disease, as she shares her experience accessing cognitive therapy.